---
title: "IMMX.US (IMMX.US) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/IMMX.US/news.md"
symbol: "IMMX.US"
name: "IMMX.US"
parent: "https://longbridge.com/en/quote/IMMX.US.md"
datetime: "2026-03-10T19:44:43.062Z"
locales:
  - [en](https://longbridge.com/en/quote/IMMX.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/IMMX.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/IMMX.US/news.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/quote/IMMX.US/news.md) | [繁體中文](https://longbridge.com/zh-HK/quote/IMMX.US/news.md)


# IMMX.US (IMMX.US) — Related News

### [Immix Biopharma, Inc. (NASDAQ:IMMX) Receives Average Rating of "Hold" from Analysts](https://longbridge.com/en/news/278388728.md)
*2026-03-09T12:08:45.000Z*
> Immix Biopharma, Inc. (NASDAQ:IMMX) has received an average analyst rating of "Hold" from five firms. One analyst rated 

### [This Aktis Oncology Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday](https://longbridge.com/en/news/278382597.md)
*2026-03-09T11:17:11.000Z*
> Top Wall Street analysts have initiated coverage on several stocks with bullish ratings. Keybanc's Sangita Jain rated So

### [Immix Biopharma Inc. unveils new presentation on relapsed/refractory AL amyloidosis treatment challenges](https://longbridge.com/en/news/274846044.md)
*2026-02-04T16:51:03.000Z*
> Immix Biopharma Inc. has unveiled a presentation addressing the unmet needs in treating relapsed/refractory AL amyloidos

### [BUZZ-Immix climbs on FDA's 'breakthrough' tag for blood disorder therapy](https://longbridge.com/en/news/274000671.md)
*2026-01-28T14:01:32.000Z*
> Shares of Immix Biopharmarose 4.4% to $6.20 in premarket trading after the U.S. FDA granted a ‘breakthrough therapy’ des

### [FDA Grants Breakthrough Therapy Designation to Immix Biopharma's NXC-201 for AL Amyloidosis](https://longbridge.com/en/news/273998495.md)
*2026-01-28T13:45:13.000Z*
> Immix Biopharma Inc. has received Breakthrough Therapy Designation from the FDA for its therapy NXC-201, aimed at treati

### [Immix Biopharma (IMMX) Shares Slip As Investors Focus On Plans To Offer And Sell $750 Million In Securities](https://longbridge.com/en/news/272295439.md)
*2026-01-12T15:48:11.000Z*
> Immix Biopharma Inc (NASDAQ: IMMX) shares fell 4.11% to $4.67 after the company filed a new shelf registration statement

### [Immix Biopharma CFO Gabriel S. Morris Reports Acquisition of Common Shares](https://longbridge.com/en/news/269299521.md)
*2025-12-10T23:47:49.000Z*
> Gabriel S. Morris, CFO and Director of Immix Biopharma Inc., reported acquiring common shares of the company. The inform

### [Immix Biopharma Announces Closing of Upsized $100 Million Underwritten Offering of Common Stock and Pre-Funded Warrants | IMMX Stock News](https://longbridge.com/en/news/269145773.md)
*2025-12-09T14:45:00.000Z*
> Immix Biopharma announced the closing of a $100 million underwritten offering of common stock and pre-funded warrants, r